Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Opium (Opioid) Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Opium (Opioid) Addiction (Central Nervous System) pipeline landscape. Opioid Addiction develops after using opioids regularly for a period of time. Prolonged use of opiates can lead to nerve ... Read More
-
Artificial Intelligence in Digital Genome Market, by Offering (Software and Services), by Technology (Machine Learning and Computer Vision), by Functionality (Genome Sequencing and Gene Editing), by Application (Diagnostics, Drug Discovery & Development,
... & Animal Research, and Other Applications), by End User (Pharmaceutical & Biotech Companies and Research Bodies), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity ... Read More
-
Global RNA Therapeutics Growth Opportunities
... pathways. Technologically advanced platforms are integrated into RNA therapeutics bioprocessing to overcome stability issues. Technological advantages, coupled with the growing need to build clinically superior portfolios in RNA therapeutics for a competitive edge, are anticipated ... Read More
-
Premature Labor (Tocolysis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Premature Labor (Tocolysis) (Women's Health) pipeline landscape. Preterm labor or premature labor is defined as labor that begins before completion of 36 weeks of pregnancy. Symptoms include sensation ... Read More
-
Influenza A Virus, H5N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... H5N1 Subtype Infections - Drugs In Development, 2022, provides an overview of the Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline landscape. H5N1 is a type of influenza virus that causes a highly infectious, ... Read More
-
Epstein-Barr Virus (HHV-4) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline landscape. Epstein-Barr virus (EBV) or human herpes virus 4 virus is a member of the Herpesviridae family. It is ... Read More
-
Myocardial Infarction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape. Myocardial infarction is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest, jaw pain, ... Read More
-
Rhinovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Rhinovirus Infections (Infectious Disease) pipeline landscape. Rhinoviruses are common cause of the common cold. The virus can spread through droplets in the air when someone who is sick coughs, sneezes ... Read More
-
Actinic (Solar) Keratosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Actinic (Solar) Keratosis (Dermatology) pipeline landscape. An actinic keratosis, also known as a solar keratosis, is a scaly or crusty growth (lesion). It most often appears on the ... Read More
-
Friedreich Ataxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Friedreich Ataxia (Central Nervous System) pipeline landscape. Friedreich’s ataxia (FA) is a neuromuscular disease that mainly affects the nervous system and the heart. FA is a hereditary disease, caused by ... Read More
-
Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) pipeline Target constitutes close to 7 molecules. Out of which approximately 7 molecules are developed by Companies. The latest report Calcitonin Gene Related Peptide Type ... Read More
-
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... or GRM1) - Metabotropic glutamate receptor 1 (mGluR1) is a protein encoded by GRM1. It activates a phosphatidylinositol-calcium second messenger system. It participates in the central action of glutamate in the CNS, such as long-term ... Read More
-
Somatostatin Receptor Type 4 (SSTR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... molecules. Out of which approximately 5 molecules are developed by Companies. The latest report Somatostatin Receptor Type 4 - Drugs In Development, 2022, outlays comprehensive information on the Somatostatin Receptor Type 4 (SSTR4) targeted therapeutics, ... Read More
-
Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Glutamate Receptor 7 - Drugs In Development, 2022'; Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and ... Read More
-
Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... constitutes close to 5 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the universities/institutes. The latest report Neuronal Acetylcholine Receptor Subunit Alpha 4 - Drugs In Development, 2022, outlays ... Read More
-
Computational Biology Market, By Type (Cellular & Biological Simulation (Computational Genomics, Computational Proteomics, Pharmacogenomics, Others (Transcriptomics/Metabolomic)), Disease Modeling and Simulation Applications (Drug Discovery, Drug Developm
... and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Computational Biology are used of data-analytical and theoretical methods, mathematical modeling ... Read More
-
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research
... in a beneficial way that may effectively treat a wide variety of infectious diseases (ID) ranging from cancer to psychiatric disorders, and even COVID-19. There are currently 23 drugs in clinical development that target the ... Read More
-
Deep Vein Thrombosis (DVT) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline landscape. Deep venous thrombosis is a blood clot that forms in a vein deep inside a part of the body. ... Read More
-
Pulmonary Arterial Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in ... Read More
-
Malignant Pleural Effusion Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Malignant Pleural Effusion (Respiratory) pipeline landscape. Malignant pleural effusion is a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of ... Read More
-
Hypopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Hypopharyngeal Cancer (Oncology) pipeline landscape. Hypopharyngeal cancer is a term used for tumors of a subsite of the upper aerodigestive tract, and like most other subsite designations, the distinction is ... Read More
-
Neuromyelitis Optica (Devic’s Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline landscape. Neuromyelitis optica (NMO), also known as Devic's disease, is an uncommon neurological condition caused by disease or ... Read More
-
Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Dyskinesia (Central Nervous System) pipeline landscape. Dyskinesia refers to the involuntary nature of muscular movements or the difficulty in performing voluntary muscular movement. Symptoms include facial grimacing, finger movement, jaw swinging, repetitive ... Read More
-
Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... acetylcholine receptor subunit beta-2 is a protein encoded by the CHRNB2 gene. Acetylcholine binds to this receptor. This results in extensive change in conformation that affects all subunits and leads to opening of an ion-conducting ... Read More
-
Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) pipeline Target constitutes close to 6 molecules. Out of which approximately 6 molecules are developed by Companies. The latest report Bromodomain Testis Specific Protein - ... Read More
Research Assistance
